Es wird erwartet, dass die Zelltherapie-Bioverarbeitung im Jahr 2028 30.052,61 Millionen US-Dollar erreichen wird, gegenüber 11.192,50 Millionen US-Dollar im Jahr 2020. Es wird geschätzt, dass der Markt von 2021 bis 2028 mit einer jährlichen Wachstumsrate von 13,5 % wächst.
Die Der Markt für Zelltherapie-Bioverarbeitung wurde auf der Grundlage von Technologie, Zelltyp, Endbenutzer und Region analysiert. Der regionale Markt ist in Nordamerika, Europa, den asiatisch-pazifischen Raum, den Nahen Osten und Afrika sowie Süd- und Mittelamerika unterteilt. Der Bericht legt den Schwerpunkt auf Parameter wie Markttrends, technologische Fortschritte, Marktdynamik und die Analyse der Wettbewerbslandschaft führender Unternehmen, um Einblicke und eine eingehende Analyse des Marktes für Zelltherapie-Bioverarbeitung zu bieten. Es umfasst auch die Analyse der COVID-19-Pandemie im gesamten Markt in allen Schlüsselregionen.
Lukrative Regionen für den Zelltherapie-Bioverarbeitungsmarkt
Markteinblicke
Wachsende Zulassungen für Zelltherapien
Zelltherapien haben bei der Behandlung positive Ergebnisse gezeigt verschiedene chronische Krankheiten, einschließlich seltener genetischer Störungen, durch das Angebot regenerativer Medikamente und personalisierter Medikamente. Der zunehmende Bedarf an der Behandlung chronischer Krankheiten hat die Forschungs- und Entwicklungsaktivitäten vorangetrieben, was zu einer wachsenden Produktion von Zelltherapien und Produktzulassungen geführt hat. Nachfolgend sind einige Beispiele für die Zulassungen von Zelltherapien aufgeführt, die zum Wachstum des Marktes für Zelltherapie-Bioverarbeitung beigetragen haben.
- Im Mai 2019 genehmigte die Food and Drug Administration (FDA) Zolgensma, hergestellt von AveXis, Inc., einer Tochtergesellschaft der Novartis AG. Zolgensa wurde zur Behandlung von spinaler Muskelatrophie bei Kindern unter zwei Jahren entwickelt und wird durch einmalige Infusion in die Vene verabreicht.
- Im Juli 2020 erhielt Kite Pharma, Inc., eine Tochtergesellschaft der Gilead Company, die FDA Genehmigung für seinen Tecartus. Tecartus ist eine (CAR) T-Zelltherapie zur Behandlung des refraktären Mantelzelllymphoms (MCL) bei Erwachsenen. Laut toe Gilead Company ist Tecartus die erste zugelassene (CAR) T-Zelltherapie für Mantelzell-Lymphom, die voraussichtlich eine neue Grenze in der Behandlung von Mantelzell-Lymphom darstellen wird.
- Im Februar 2021 veröffentlichte Juno Therapeutics, Inc., eine Tochtergesellschaft der Bristol-Myers Squibb Company, hat die Zulassung für sein Breyanzi erhalten. Breyanzi ist eine zellbasierte Gentherapie zur Behandlung bestimmter Arten großzelliger B-Zell-Lymphome bei Erwachsenen. Die Behandlung wird durchgeführt, wenn der Patient auf mindestens zwei andere Arten systemischer Behandlungen nicht angesprochen hat. Allerdings musste Breyanzi im Jahr 2019 seit seinem ersten Antrag einen regulatorischen Rückschlag hinnehmen; Es befindet sich derzeit in der Prüfung der Europäischen Arzneimittel-Agentur und wurde im Juli 2020 validiert.
So haben zunehmende Produktentwicklungen zu verschiedenen Produktzulassungen geführt, was die Zunahme von Zelltherapien widerspiegelt. Daher wird erwartet, dass die zunehmenden Zulassungen für Zelltherapien die Zelltherapie-Bioverarbeitung enorm steigern werden, was wiederum wahrscheinlich das Wachstum des Marktes in den kommenden Jahren vorantreiben wird
Technology-Based Insights
Der Markt für Zelltherapie-Bioverarbeitung ist nach Technologie in Bioreaktor, Lyophilisierung, Elektrospinnen, Kontrollflusszentrifugation, Ultraschalllyse, Genomeditierungstechnologie, Zellimmortalisierungstechnologie und virale Vektortechnologie unterteilt. Das Segment Bioreaktoren hielt im Jahr 2020 den größten Marktanteil, während das Segment der Genombearbeitungstechnologie im Prognosezeitraum voraussichtlich die höchste CAGR von 14,5 % auf dem Markt verzeichnen wird.
Markt für Zelltherapie-Bioverarbeitung, von Technologie 2020 und 2028
Zelltypbasierte Erkenntnisse
Der Zelltherapie-Bioverarbeitungsmarkt ist nach Zelltyp in Stammzellen, Immunzellen, menschliche embryonale Stammzellen und pluripotente Stammzellen unterteilt Zelle, hämatopoetische Stammzellen. Das Stammzellensegment hatte im Jahr 2020 den größten Marktanteil, während dasselbe Segment im Prognosezeitraum voraussichtlich die höchste CAGR von 14,0 % auf dem Markt verzeichnen wird.
Endbenutzerbasierte Erkenntnisse
Der Markt für Zelltherapie-Bioverarbeitung ist je nach Indikation in Herz-Kreislauf-Erkrankungen (CVD), Onkologie, Wundheilung, Orthopädie und andere unterteilt. Das Onkologie-Segment hatte im Jahr 2020 den größten Marktanteil und das Orthopädie-Segment wird im Prognosezeitraum voraussichtlich die höchste CAGR von 14,3 % auf dem Markt verzeichnen.
Strategische Einblicke
Unternehmen, die auf dem Markt für Zelltherapie-Bioverarbeitung tätig sind, wenden organische Strategien wie Produkteinführungen und -erweiterungen an, um ihre Präsenz und ihr Produktportfolio weltweit zu erweitern und den wachsenden Anforderungen gerecht zu werden.
Nach Technologie
< ul>
Nach Zelltyp
- Stammzelle
- Immunzelle
- Menschliche embryonale Stammzelle
- Pluripotente Stammzelle
- Hämatopoetische Stammzelle
Nach Indikation< /p>
- Herz-Kreislauf-Erkrankungen (CVD)
- Onkologie
- Wundheilung
- Orthopädie
- Andere
Nach Endbenutzer
- Krankenhäuser und Kliniken
- Diagnosezentren
- Zentren für regenerative Medizin
- Akademisches und Forschungsinstitut
Nach Geographie
- Nordamerika
- USA
- Kanada
- Mexiko
- Europa
- Frankreich
- Deutschland
- Italien
- Großbritannien< /li>
- Spanien
- Restliches Europa
- Asien-Pazifik (APAC)
- China
- Indien
- Südkorea
- Japan
- Australien
- Rest von APAC
< li>Naher Osten und Afrika (MEA) - Südafrika
- Saudi-Arabien
- VAE
- Rest von MEA
- Süd- und Mittelamerika (SCAM)
- Brasilien
- Argentinien
- Rest von SCAM
- Fresenius Kabi AG
- Asahi Kasei Corporation
- Sartorius AG
- MERCK KGaA
- THERMO FISHER SCIENTIFIC INC.
- Corning Incorporated
- Cytiva
- Lonza
- Repligen
- Catalent Inc
Unternehmensprofile
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and bioprocessing (i.e., biopharmaceutical manufacturing). Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat disease.
Key factors driving the growth of the market are increasing investments for cell and gene therapy manufacturing, and growing approvals for cell therapies are the major factors driving the market growth. However, challenges such as high cost of product, regulatory challenges, and logistics challenges are likely to hinder the growth of the cell therapy bioprocessing market.
The costs of the Cell Therapy Bioprocessing are much higher, and they may cost US$ 50,000–100,000, or more, per cell therapy. The cost may also differ from product to product types.
The List of Companies - Cell Therapy Bioprocessing Market
- Fresenius Kabi AG
- Asahi Kasei Corporation
- Sartorius AG
- MERCK KGaA
- THERMO FISHER SCIENTIFIC INC.
- Corning Incorporated
- Cytiva
- Lonza
- Repligen
- Catalent Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)